Showing results (1-10 of 204) with videos related to
Sort By:
Pageof 21
Cardiovascular Diabetology|September 10, 2009
Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulationFederico Biscetti, Giuseppe Straface, Vincenzo Arena, et al.Diabetes|March 5, 2010
High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanismFederico Biscetti, Giuseppe Straface, Raimondo De Cristofaro, et al.Journal of Vascular Surgery|December 3, 2014
Identification of a potential proinflammatory genetic profile influencing carotid plaque vulnerabilityFederico Biscetti, Giuseppe Straface, Giovanni Bertoletti, et al.Current Vascular Pharmacology|July 10, 2015
New therapeutic effects of cilostazol in patients with ischemic disordersFederico Biscetti, Gianfranco Ferraccioli, Andrea FlexCurrent Vascular Pharmacology|June 23, 2011
Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regenerationFederico Biscetti, Giovanni Ghirlanda, Andrea FlexCardiovascular Diabetology|August 10, 2017
Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjectsSilvia Giovannini, Giovanni Tinelli, Federico Biscetti, et al.International Journal of Cardiology|April 5, 2012
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanismFederico Biscetti, Giovanni Pecorini, Giuseppe Straface, et al.Human Genetics|September 12, 2012
Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patientsFederico Biscetti, Giuseppe Straface, Silvia Giovannini, et al.Neuro-Degenerative Diseases|September 12, 2013
Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's diseaseAndrea Flex, Silvia Giovannini, Federico Biscetti, et al.Journal of Vascular Research|July 12, 2008
Peroxisome proliferator-activated receptor alpha is crucial for iloprost-induced in vivo angiogenesis and vascular endothelial growth factor upregulationFederico Biscetti, Eleonora Gaetani, Andrea Flex, et al.Pageof 21